Combination of Doxorubicin and Areca Ethanolic Extract Induces Apoptosis by Increasing Caspase-3 Level on Breast Cancer (T47D) Cells by Rahmi, Fitria et al.
Indonesian Journal of Cancer Chemoprevention, February 2012 
ISSN: 2088–0197 
e-ISSN: 2355-8989 
339 
 
Combination of Doxorubicin and Areca Ethanolic 
Extract Induces Apoptosis by Increasing Caspase-3 Level 
on Breast Cancer (T47D) Cells 
 
Fitria Rahmi
1*
, Edy Meiyanto
2
,
 
Ratna Asmah Susidarti
2
 
 
1Drug and Food Research Center, National Agency of Drug and Foods Controls, Republic of Indonesia 
2Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia 
 
 
Abstract 
 
Despite causing many side effects, doxorubicin (Dox) is still one of breast cancer drug 
of choice. Thus, combination of chemotherapy is developed in order to decrease 
doxorubicin regimen dose. The aim of this research is to examine the combination effect of 
doxorubicin (dox) and areca extract (AE) on T47D human breast cancer cells. The cytotoxic 
activity was determined using MTT assay. The combination index (CI) of the combination 
treatment was calculated to determine the effects (synergistic, additive or antagonistic). The 
combination application of dox (6-22nM) and AE (8-30µg/ml) on T47D cells showed 
synergistic (CI<0.9) or additive effect (CI=0.9-1.1). The effective combination of dox-AE was 
6 nM - 8 µg/mL on CI<0.5. Apoptosis induction of AE solely and its combination with dox 
was then observed using double staining method. Moreover, expression of Bax and caspase-3 
protein which mediated apoptosis, were observed using immunocytochemistry. Combination 
of AE and Dox increased expression of Caspase-3 but did not increase expression of Bax. 
This result showed AE increase the effectiveness of doxorubicin against T47D cells.  
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INTRODUCTION 
 
Chemotherapy is the most effective 
therapy for all stages of breast cancers. 
Doxorubicin is a chemotherapeutic agent which 
is widely used for breast cancers (Smith, et al., 
2006). Doxorubicin interacts with DNA by 
covalent binding thus inhibit DNA synthesize 
and RNA-polymerase activity (Mullin and 
Claude, 1998). Beside, doxorubicin generates 
reactive oxygen species (ROS) which initiate 
series of reaction disturbing cell integrity (Fang 
and Iyer, 2007). Long term use of doxorubicin 
induces hepatotoxicity and haematopoietic 
imbalance (Arai, et al., 2000; Jemal, et al., 
2005), and resistance mediated by P-
glycoprotein (Pgp) overexpression. Pgp 
effluxes drug from the cell and reduces drug 
intracellular (Thomas and Coley, 2003). 
Pinang seed (Areca catechu L.) is used 
for traditional food spice. Meiyanto, et al. 
(2008) reported that ethanolic extract of pinang 
seed inhibit MCF-7 breast cancer cells 
proliferation and induces apoptosis. MCF-7 is  
p53 expressing cells. Ethanolic extract of 
pinang seed also showed antioxidant activity 
with IC50 value of 45.5 µg/mL 
(Wetwitayaklung, et al., 2006). Antioxidant 
activity is usually correlated with cancer 
prevention. Thus, a combination of 
chemotherapeutic agent and chemopreventive 
agent which has been known to increase 
anticancer activity and decrease side effects, is 
an effective strategy to cure cancer 
(Wetwitayaklung, et al., 2006). 
Normally, apoptosis is occured to 
achieve homeostatic condition. Nevertheless, 
cancer cells which are genetically modified 
have ability to avoid apoptosis (Hanahan and 
Weinberg, 2011). This research was conducted 
to observe combination effect of doxorubicin 
(Dox) and areca extract (AE) on cell 
cytotoxicity, induction of apoptosis, and 
mechanism mediated apoptosis on T47D breast 
cancer cells. 
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MATERIALS AND METHODS 
 
Materials 
Ethanolic extract of pinang seed/areca 
extract used in this research was prepared and 
standardized based on Meiyanto, et al. (2008). 
T47D cells were a collection of CCRC (Cancer 
Chemoprevention Research Center) Faculty of 
Pharmacy UGM which is originaly obtained 
from Laboratory of gene function, NAIST, 
Japan. Cells were grown in medium cultur 
DMEM (Dulbecco’s modified Eagle’s Medium) 
contains FBS (Fetal Bovine Serum) 10% and  
penicillin-streptromicin 1% (Gibco). Tripsin-
EDTA was used to dettached cells on the flask. 
 
Cytotoxic Assay 
Cytotoxic assay of Dox and AE alone 
against T47D cells were conducted to 
determine concentration used in combination 
cytotoxic assay. Cytotoxic assay was done 
using MTT, as validated by Itagaki, et al. 
(1998). T47D cells (3x10
3
 cells/well) were 
suspended in 100 L of culture medium. Dox 
(nM) and AE (g/mL) concentration used in the 
combination assay are 22-30, 11-30, 22-15, 11-
15, 6-15, 11-8, 6-8. Combination index was 
calculated based on equation from 
Notarbartolo, et al. (2005). 
 
Apoptosis Detection 
Apoptosis was detected using acrydine 
orange-ethidium bromide staining (AO/EB 
double staining). T47D cells (3 x 10
4
 cells/well) 
were seeded on coverslips in 24- well plates 
until 50-60% confluent. Cells were then 
incubated with AE alone, Doxorubicin alone or 
their combination for 48 h. Culture medium 
was removed and cells were washed with PBS. 
Coverslips were placed into object-glass and 
added with 10 μL of 1x working solution 
acrydine orange (Sigma)-ethidium bromide 
(Sigma), observed using fluoroscence 
microscopy (Zeiss MC 80). Apoptotic cells 
which had lost their membrane integrity 
appeared orange and showed morphological 
features of apoptosis. Cells were identified as 
apoptotic cells based on the specific 
morphological criteria, including condensation 
and fragmentation of chromatin, and formation 
of apoptotic bodies. 
 
Immunocytochemistry 
Cells were plated at 3x10
4
 cells/well and 
cultured in 24-wells plate at cover slip until 80 
% confluent. When the cells were ready to be 
treated, medium was replaced by fresh 
complete medium with AE 24 μM and 
doxorubicin 500 nM and incubated in CO2 5% 
incubator at 37
o
C for 18 hours. Then, cells were 
harvested and were washed with PBS and fixed 
with cold methanol for 10 min at freezer -40C. 
Cells were washed, and blocked in hydrogen 
peroxide blocking solution for 10 minutes at 
room temperature. After that, cells were washed 
with PBS and incubated with prediluted 
blocking serum for 10 minutes at room 
temperature. Cells were stained for 1 h at room 
temperature with primary Ab (caspase-3 and 
Bax). After being washed three times in PBS, 
secondary antibody were applied for 15-30 min, 
1 : 2 in PBS and added with 5% AB serum then 
washed with PBS for three times. The slide was 
incubated with streptavidin-biotin complex for 
15 min, 1 : 2 in PBS and added 5% AB serum 
and washed three times in PBS. Slides were 
incubated in DAB (3,3diaminobenzidin) 
solution for 3-8 min and washed with aquadest. 
Cells were counterstained for 3-4 min with 
Mayer-Haematoxylin. After incubation, 
coverslip were washed with aquadest and 
immersed. Protein expression was assessed 
under light microscope. Positive expression will 
give a dark brown colour in nucleus and cells 
with no expression will give purple colour. 
 
RESULTS AND DISCUSSION 
 
Effect of Areca Extract (AE) and 
Doxorubicin Solely on T47D Cells 
Viability 
Doxorubicin showed cytotoxic effect on 
T47D cells in dose dependent manner 
(Fig.1(A)). At the concentration of 32 nm, dox 
inhibited 50% of cell viability. AE also showed 
cytotoxic effect on T47D cells (Fig.1(B)). 
Based on linier regression between log of 
concentration and cell viability percentage 
(p<0.05), IC50 value of AE is 50 µg/mL. 
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Figure 1. Cytotoxic effect of Doxorubicin and Ethanolic extract of Areca (AE) on T47D cells. IC50 
values obtained from the calculation of linear regression of concentration vs % viable cells 
with p<0.05. (A) doxorubicin (10-100 nM) and (B) AE (30-210 µg/ml) . Cell viability were 
obtained from the conversion of absorbance values of formazan that was formed by MTT 
treatment as described in the method. AE and Dox cytotoxicity expressed by percent cell 
viability is shown as the mean + SE of 3 experiments. 
 
Effect of Combination of AE and 
Doxorubicin on T47D Cells Growth 
Combination index at combination of 
doxorubicin and AE is presented in Table I. 
Almost all of combination gave synergistic 
effect (CI<0.9). However, dox 22 nM combined 
with AE 15µg/ml gave additive effect (CI 0.9-
1.1). Based on these results, combination 
treatment showed increase cytotoxicity of 
doxorubicin.
  
Table I . Combination index value given by combination of dox and AE 
EP (µg/ml) 
Dox (nM) 
22 11 6 
30 0,86 0,79 - 
15 0,96 0,66 0,60 
8 - 0,66 0,35 
 
Effect of Combination of AE and 
Doxorubicin on Apoptosis 
Apoptosis induction on T47D cells was 
observed after 48 hours of incubation. Cells 
were treated with AE (60 µg/mL), doxorubicin 
(44 nM), or combination of them. AE and dox 
induced T47D cells apoptosis for 5% and 6%, 
respectively (Fig.2). Combination of AE and 
dox increase apoptosis induction (23%) 
compared to each compound. This result 
showed synergistic effect between dox and AE.
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Figure 2. Effect of AE and Dox on T47D cells apoptosis using acridine orange-ethidium bromide 
staining. (A) Cell morphology after treated with (a) doxorubicin 44 nM (b) AE 60µg/mL (c) 
untreated (d) combination of dox-AE. (B) Apoptosis quantification graphic. Apoptotic  cell 
(        )   and viable cell (        ) 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of AE and Dox on Bax and Caspase 3 expression in T47D cells. Bax and caspase 3 
expression was observed using immunocytochemistry as described in method and treated 
with (A) cells without Bax antibody (B) control with Bax-Ab (C) dox 70nM with Bax-Ab (D) 
AE 70µg/mL with Bax-Ab (E) combination of Dox-AE with Bax-Ab (F) control with caspase-
3-Ab (G) dox 70nM with caspase-3-Ab (H) AE 70µg/ml with caspase-3-Ab (I) combination of 
Dox-AE with caspase-3-Ab. Cells were observed under light microscope with 100x 
magnification. cells expressed caspase-3(    ) cells did not expressed caspase-3 (        )     
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Effect of Combination of AE and 
Doxorubicin on Bax and Caspase-3 
Expression 
To confirm the mechanism of AE and its 
combination with doxorubicin induced 
apoptosis, we observed the effect of AE, 
doxorubicin or their combination on the 
expression of Bax, and caspase-3 by using 
immunocytochemistry method. However, AE 
and Dox did not increase Bax level (Fig. 3(B-
E)). On the other hand, all treatment increased 
caspase-3 level, especially on the combination 
treatment (Fig.3 (F-I)). This result indicates 
there are increase of caspase-3 level by all 
treatment, especially by combination treatment. 
These data showed that the combination was 
more potent to induce apoptosis on the T47D 
cells than single treatment. 
Generally assumed that plant extract 
with IC50 < 100 µg/ml is potential to be 
developed as anticancer agent (Ueda, et al., 
2002). Accordingly, the results of this study 
demonstrated potency of areca extract (AE) to 
be developed as anticancer agent, showed by its 
IC50 on T47D cells.  Doxorubicin as drug of 
choice for breast cancer has been related with 
resistance phenomenon in time and dose 
dependent manner. Moreover, AE showed 
synergistic effect when combined with 
doxorubicin, demonstrated its potency to reduce 
doxorubicin resistance in cancer cells. 
Cytotoxic properties can be associated 
with the ability to spur occurrence of cell cycle 
arrest and/or accelerate apoptosis on cells. We 
found that AE and its combination with 
doxorubicin induced apoptosis on T47D cells. 
There are two mechanisms mediating 
apoptosis: extrinsic pathway via death receptor 
and intrinsic pathway via mitochondria. Some 
proteins involved in apoptosis, such as Bax. 
Bax translocation from cytosol to mitochondria 
caused apoptosis on staurosporine treated T47D 
cells (Mooney, et al., 2002). Bax must form a 
dimer to enter mitochondria (Korsmeyer, et al., 
2000). In the cells without apoptosis signal, 
Bax binds to Bcl-2, an antiapoptotic protein. 
Bcl-2 overexpression lead to apoptosis 
resistance. In contrast, decrease of Bcl-2 level 
caused increasing of dimer Bax leading to 
apoptosis. Beside Bax, caspase-3 activation 
also involved in apoptosis. Caspase-3 is an 
effector protein to initiate cell degradation. 
Apoptosis occured in staurosporine induced 
T47D cells was estimated through caspase-3 
activation. Therefore, we observed caspase-3 
status on T47D cells treated with AE and Dox. 
Our study showed that AE and its 
combination with doxorubicin increased 
cleaved caspase-3 level but not Bax level. Bax 
expression is affected by its upstream protein, 
p53. In T47D cells, p53 protein has been 
mutated, thus apoptosis induction caused by 
combination of Dox-AE may not be mediated 
through p53 pathways. Further mechanism 
related with apoptosis induction is needed to be 
observed, such as increase the activation of 
caspase-3 or related with apoptosis extrinsic 
pathways. Overall, AE increases the 
effectiveness of doxorubicin. Nevertheless, this 
result needs further research to explore the 
potential of doxorubicin combined with Areca, 
especially the molecular mechanisms facilitated 
in increasing effect of doxorubicin. 
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